BNP PARIBAS ASSET MANAGEMENT Holding S.A.
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1520354
Paris, I0
Position in RXRX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,428,280
-$839,948 QoQ
Shares Held
790,971
-1.0% QoQ
Ownership
0.149%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $2,095,512,918 across 139 Biotechnology names. RXRX ranks #56 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
848,047 | $378,686,906 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
273,120 | $211,023,436 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
885,201 | $167,347,247 | |
| 4 | ARGX |
Argenx SE
|
129,147 | $94,309,595 | |
| 5 | INCY |
Incyte Corp
|
938,848 | $88,364,372 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
1,342,028 | $78,038,926 | |
| 7 | INSM |
INSMED Inc
|
467,753 | $76,486,969 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
907,533 | $68,146,652 |
All Filings in RXRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,428,280 | 790,971 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $3,268,228 | 799,078 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $14,410 | 2,953 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $13,252 | 2,619 | Shares | Defined | 2025-08-06 | |
| No filing history on record for this holder in this stock. | ||||||